Orchestra BioMed operates with a lean, specialized corporate team consisting of approximately 85 to 93 full-time professional employees. This workforce includes executive management, clinical research scientists, regulatory affairs experts, and administrative personnel who manage its core biomedical research pipeline and strategic corporate partnerships. Rather than maintaining massive internal commercial manufacturing or global sales workforces, the enterprise leverages external strategic alliances to scale its clinical development and operational distribution requirements efficiently.